Hooshmand Sheshbaradaran

Hoboken, NJ (USA)
Role(s):
Founder/Owner/Principal

Niiki Pharma Inc

Location: Hoboken
Industry: Bio-Technology
Year Founded: 2007
Number Employees: 1-10 people
Business Stage: Growth (not profitable)
Entity Type: "C" Corporation
Description: Niiki Pharma (Hoboken, NJ) is developing first-in-class breakthrough cancer treatments which have already shown significant promise in the ongoing clinical trials, treating terminal cancer patients with no option of treatment. World class oncologists lead the trials for Niiki Pharma. The company has been successful in obtaining two FDA IND approvals in the past 3 years. The company is seeking to raise $4 Mil (as remaining part of a convertible note) to bridge to licensing or potential sale of its products. This convertible note has very attractive terms and $2M has already been raised. The company would also be open to raise the funds through equity financing of $5 M or more. The proceeds will be used to complete the ongoing clinical trials and generate revenue via license or sale of the assets.